Elevation Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Net Income	-0.13	-0.11	-0.02	-0.03	-0.02	-0
Depreciation & Amortization	0	0	0	-	-	-
Loss (Gain) From Sale of Assets	0	0	-	-	-	-
Change in Accounts Payable	0	0.01	-0.01	0.01	-	-
Operating Cash Flow	-0.12	-0.1	-0.03	-0.02	-0.02	-0
Capital Expenditures	-	-	-0	-	-	-
Investing Cash Flow	-	-	-0	-	-	-
Short-Term Debt Issued	-	0.1	0.03	0.01	0	0
Total Debt Issued	0.14	0.1	0.03	0.01	0	0
Net Debt Issued (Repaid)	0.14	0.1	0.03	0.01	0	0
Issuance of Common Stock	-	-	-	-	0.03	0
Financing Cash Flow	0.14	0.1	0.03	0.01	0.03	0.01
Net Cash Flow	0.01	0	-0.01	-0.01	0.01	0
Free Cash Flow	-0.12	-0.1	-0.04	-0.02	-0.02	-0
Free Cash Flow Margin	-	-	-441.44%	-	-	-
Free Cash Flow Per Share	-0.03	-0.02	-0.01	-0.01	-0.01	-0.01
Levered Free Cash Flow	-0.08	-0.06	-0.03	-0.01	-0.01	-
Unlevered Free Cash Flow	-0.08	-0.06	-0.03	-0.01	-0.01	-
Change in Net Working Capital	-0	-0.01	0.01	-0.01	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.